#391 ‒ Colorectal cancer screening: importance of early screening, colonoscopy as a screening and preventive tool, and how to build a personalized strategy

What It Covers

Peter Attia covers colorectal cancer screening, explaining why CRC is uniquely preventable, how colonoscopy functions as both detection and prevention, the rise of early-onset cases in younger adults, and how to evaluate noninvasive screening alternatives.

Key Questions Answered

• •Preventability window: Colorectal cancer progresses from normal tissue to malignancy over a decade or more, creating a long intervention window. A 2020 CDC estimate suggests 68% of CRC deaths are preventable with standard screening intervals alone — a figure Attia argues could reach 100% with earlier, more frequent screening.
• •Colonoscopy as dual-function tool: Unlike mammograms or low-dose CT scans that only detect existing cancer, colonoscopy directly visualizes the colon and removes precancerous polyps before malignancy develops. No other common cancer screening method offers this combined detection-and-prevention capability in a single procedure.
• •Early-onset CRC trend: Colorectal cancer is rising among younger adults, making the question of when to start screening increasingly relevant. Attia frames the episode to address people as young as 35 who are uncertain about screening timing, not just those in traditional 50+ screening age brackets.
• •Noninvasive test limitations: Stool-based tests like Cologuard and emerging blood-based tests offer alternatives to colonoscopy but carry meaningful limitations. Understanding what these tests can and cannot detect is necessary before treating them as equivalent substitutes for direct colonoscopic examination and polyp removal.